ClearPoint Neuro, Inc. (CLPT)

$12.51

-0.54 (-4.14%)
Rating:
Recommendation:
-
Symbol CLPT
Price $12.51
Beta 1.250
Volume Avg. 0.24M
Market Cap 296.703M
Shares () -
52 Week Range 7.0-22.8
1y Target Est -
DCF Unlevered CLPT DCF ->
DCF Levered CLPT LDCF ->
ROE -33.94% Strong Sell
ROA -25.63% Sell
Operating Margin -
Debt / Equity 35.07% Neutral
P/E -
P/B 6.48 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest CLPT news


Mr. Joseph Michael Burnett
Healthcare
Medical Devices
NASDAQ Capital Market

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.